The authors performed Transwell assays to evaluate the migration and invasion of glioma cells and found that DLGAP1-AS1 knockdown markedly reduced the migration and invasion of U251 and U87MG cells (compared with the control group) (Fig. 2E-F). Here, DLGAP1 is linked to central nervous system cancer.